| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.869 | 0.003 | 0.932 | Non-steroidal antiinflammatory agent | 0.796 0.003 DB00328 0.846 0.003 DBMET01880 0.439 0.01 DBMET01881 0.796 0.003 DBMET01882 0.763 0.003 DBMET02185 0.313 0.025 DBMET02186 0.932 0.002 DBMET02187 | DBMET02187 | |
| 0.771 | 0.001 | 0.838 | Cyclooxygenase 3 inhibitor | 0.67 0.002 DB00328 0.77 0.001 DBMET01880 0.278 0.007 DBMET01881 0.67 0.002 DBMET01882 0.821 0.001 DBMET02185 0.364 0.004 DBMET02186 0.838 0.001 DBMET02187 | DBMET02187 | |
| 0.612 | 0.05 | 0.786 | Antiinflammatory | 0.603 0.053 DB00328 0.66 0.039 DBMET01880 0.406 0.136 DBMET01881 0.603 0.053 DBMET01882 0.685 0.034 DBMET02185 0.617 0.049 DBMET02186 0.786 0.017 DBMET02187 | DBMET02187 | |
| 0.508 | 0.004 | 0.589 | Prostaglandin antagonist | 0.589 0.004 DB00328 0.515 0.004 DBMET01880 0.434 0.004 DBMET01881 0.589 0.004 DBMET01882 0.083 0.022 DBMET02185 0.14 0.011 DBMET02187 | DBMET01882 | |
| 0.496 | 0.029 | 0.627 | Antithrombotic | 0.379 0.055 DB00328 0.536 0.024 DBMET01880 0.427 0.043 DBMET01881 0.379 0.055 DBMET01882 0.619 0.014 DBMET02185 0.591 0.017 DBMET02186 0.627 0.014 DBMET02187 | DBMET02187 | |
| 0.467 | 0.004 | 0.5 | Phospholipase A2 inhibitor | 0.389 0.005 DB00328 0.5 0.004 DBMET01880 0.275 0.018 DBMET01881 0.389 0.005 DBMET01882 0.275 0.018 DBMET02185 0.159 0.066 DBMET02186 0.311 0.012 DBMET02187 | DBMET01880 | |
| 0.432 | 0.005 | 0.433 | Insulin sensitizer | 0.406 0.006 DB00328 0.433 0.005 DBMET01880 0.292 0.018 DBMET01881 0.406 0.006 DBMET01882 0.256 0.031 DBMET02185 0.16 0.119 DBMET02186 0.252 0.033 DBMET02187 | DBMET01880 | |
| 0.419 | 0.006 | 0.451 | Cyclooxygenase inhibitor | 0.451 0.005 DB00328 0.43 0.006 DBMET01880 0.292 0.019 DBMET01881 0.451 0.005 DBMET01882 0.297 0.018 DBMET02185 0.111 0.11 DBMET02186 0.36 0.01 DBMET02187 | DBMET01882 | |
| 0.418 | 0.006 | 0.464 | Cyclooxygenase 1 inhibitor | 0.464 0.005 DB00328 0.441 0.005 DBMET01880 0.282 0.016 DBMET01881 0.464 0.005 DBMET01882 0.273 0.018 DBMET02185 0.118 0.083 DBMET02186 0.351 0.01 DBMET02187 | DBMET01882 | |
| 0.449 | 0.043 | 0.486 | Thyroid hormone antagonist | 0.486 0.036 DB00328 0.419 0.05 DBMET01880 0.423 0.049 DBMET01881 0.486 0.036 DBMET01882 | DBMET01882 | |
| 0.408 | 0.003 | 0.479 | Prostaglandin D2 antagonist | 0.479 0.003 DB00328 0.409 0.003 DBMET01880 0.307 0.003 DBMET01881 0.479 0.003 DBMET01882 0.028 0.012 DBMET02185 0.047 0.007 DBMET02187 | DBMET01882 | |
| 0.434 | 0.03 | 0.47 | Lipoxygenase inhibitor | 0.373 0.044 DB00328 0.47 0.023 DBMET01880 0.36 0.048 DBMET01881 0.373 0.044 DBMET01882 | DBMET01880 | |
| 0.404 | 0.016 | 0.434 | Anesthetic general | 0.434 0.013 DB00328 0.434 0.013 DBMET01880 0.308 0.031 DBMET01881 0.434 0.013 DBMET01882 0.311 0.03 DBMET02185 0.153 0.111 DBMET02186 0.377 0.019 DBMET02187 | DBMET01882 | |
| 0.405 | 0.018 | 0.484 | Platelet aggregation inhibitor | 0.265 0.046 DB00328 0.335 0.028 DBMET01880 0.484 0.01 DBMET01881 0.265 0.046 DBMET01882 | DBMET01881 | |
| 0.427 | 0.046 | 0.467 | Thyroid hormone beta antagonist | 0.467 0.038 DB00328 0.391 0.056 DBMET01880 0.389 0.057 DBMET01881 0.467 0.038 DBMET01882 | DBMET01882 | |
| 0.362 | 0.008 | 0.378 | Cyclooxygenase 2 inhibitor | 0.378 0.007 DB00328 0.368 0.007 DBMET01880 0.23 0.024 DBMET01881 0.378 0.007 DBMET01882 0.252 0.02 DBMET02185 0.305 0.013 DBMET02187 | DBMET01882 | |
| 0.358 | 0.006 | 0.557 | NADPH oxidase inhibitor | 0.557 0.004 DB00328 0.374 0.005 DBMET01880 0.345 0.008 DBMET01881 0.557 0.004 DBMET01882 0.188 0.038 DBMET02185 0.126 0.075 DBMET02186 0.49 0.004 DBMET02187 | DBMET01882 | |
| 0.374 | 0.033 | 0.384 | Platelet antagonist | 0.206 0.097 DB00328 0.384 0.03 DBMET01880 0.314 0.048 DBMET01881 0.206 0.097 DBMET01882 0.227 0.083 DBMET02185 0.241 0.077 DBMET02186 0.268 0.065 DBMET02187 | DBMET01880 | |
| 0.417 | 0.082 | 0.601 | Cyclophilin D inhibitor | 0.371 0.108 DB00328 0.455 0.065 DBMET01880 0.356 0.118 DBMET01881 0.371 0.108 DBMET01882 0.461 0.063 DBMET02185 0.492 0.053 DBMET02186 0.601 0.027 DBMET02187 | DBMET02187 | |
| 0.328 | 0.004 | 0.4 | Prostaglandin EP2 antagonist | 0.4 0.004 DB00328 0.338 0.004 DBMET01880 0.31 0.004 DBMET01881 0.4 0.004 DBMET01882 0.151 0.009 DBMET02185 0.11 0.016 DBMET02186 0.218 0.005 DBMET02187 | DBMET01882 | |
| 0.384 | 0.067 | 0.393 | Toll-Like receptor 7 agonist | 0.388 0.065 DB00328 0.393 0.063 DBMET01880 0.342 0.086 DBMET01881 0.388 0.065 DBMET01882 | DBMET01880 | |
| 0.383 | 0.067 | 0.393 | Toll-Like receptor agonist | 0.385 0.067 DB00328 0.393 0.063 DBMET01880 0.343 0.086 DBMET01881 0.385 0.067 DBMET01882 | DBMET01880 | |
| 0.312 | 0.049 | 0.466 | Hypoglycemic | 0.258 0.072 DB00328 0.335 0.041 DBMET01880 0.251 0.076 DBMET01881 0.258 0.072 DBMET01882 0.432 0.023 DBMET02185 0.457 0.02 DBMET02186 0.466 0.019 DBMET02187 | DBMET02187 | |
| 0.298 | 0.043 | 0.474 | Cyclic AMP phosphodiesterase inhibitor | 0.423 0.014 DB00328 0.295 0.044 DBMET01880 0.474 0.008 DBMET01881 0.423 0.014 DBMET01882 0.277 0.051 DBMET02185 0.365 0.022 DBMET02186 0.43 0.013 DBMET02187 | DBMET01881 | |
| 0.317 | 0.087 | 0.706 | Transcription factor NF kappa B inhibitor | 0.295 0.097 DB00328 0.376 0.069 DBMET01880 0.325 0.084 DBMET01881 0.295 0.097 DBMET01882 0.459 0.051 DBMET02185 0.504 0.044 DBMET02186 0.706 0.02 DBMET02187 | DBMET02187 | |
| 0.251 | 0.022 | 0.261 | Succinate dehydrogenase inhibitor | 0.226 0.032 DB00328 0.261 0.019 DBMET01880 0.216 0.037 DBMET01881 0.226 0.032 DBMET01882 | DBMET01880 | |
| 0.256 | 0.03 | 0.331 | Diuretic | 0.211 0.04 DB00328 0.331 0.018 DBMET01880 0.151 0.077 DBMET01881 0.211 0.04 DBMET01882 0.133 0.092 DBMET02185 0.118 0.108 DBMET02186 0.181 0.053 DBMET02187 | DBMET01880 | |
| 0.223 | 0.004 | 0.228 | Peroxisome proliferator-activated receptor gamma antagonist | 0.228 0.004 DB00328 0.175 0.005 DBMET01880 0.108 0.012 DBMET01881 0.228 0.004 DBMET01882 0.078 0.036 DBMET02187 | DBMET01882 | |
| 0.226 | 0.01 | 0.384 | Histidine decarboxylase inhibitor | 0.384 0.004 DB00328 0.363 0.004 DBMET01880 0.342 0.005 DBMET01881 0.384 0.004 DBMET01882 | DBMET01882 | |
| 0.212 | 0.023 | 0.222 | Arachidonic acid antagonist | 0.187 0.046 DB00328 0.222 0.016 DBMET01880 0.211 0.023 DBMET01881 0.187 0.046 DBMET01882 | DBMET01880 | |
| 0.24 | 0.053 | 0.323 | Platelet adhesion inhibitor | 0.251 0.049 DBMET01880 0.17 0.088 DBMET01881 0.257 0.047 DBMET02185 0.301 0.034 DBMET02186 0.323 0.027 DBMET02187 | DBMET02187 | |
| 0.19 | 0.006 | 0.198 | Amidase inhibitor | 0.192 0.006 DB00328 0.198 0.006 DBMET01880 0.192 0.006 DBMET01882 | DBMET01880 | |
| 0.175 | 0.003 | 0.233 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.233 0.003 DB00328 0.189 0.003 DBMET01880 0.05 0.009 DBMET01881 0.233 0.003 DBMET01882 | DBMET01882 | |
| 0.206 | 0.042 | 0.394 | Amylase inhibitor | 0.221 0.037 DB00328 0.246 0.029 DBMET01880 0.292 0.019 DBMET01881 0.221 0.037 DBMET01882 0.316 0.016 DBMET02185 0.39 0.01 DBMET02186 0.394 0.009 DBMET02187 | DBMET02187 | |
| 0.255 | 0.096 | 0.28 | Hypoxia-inducible factor 1 alpha inhibitor | 0.28 0.076 DB00328 0.257 0.094 DBMET01880 0.239 0.111 DBMET01881 0.28 0.076 DBMET01882 0.25 0.1 DBMET02187 | DBMET01882 | |
| 0.267 | 0.113 | 0.437 | Cholesterol antagonist | 0.231 0.139 DB00328 0.301 0.091 DBMET01880 0.309 0.085 DBMET01881 0.231 0.139 DBMET01882 0.347 0.065 DBMET02185 0.437 0.043 DBMET02186 0.397 0.05 DBMET02187 | DBMET02186 | |
| 0.162 | 0.01 | 0.169 | Peroxisome proliferator-activated receptor gamma agonist | 0.169 0.009 DB00328 0.157 0.011 DBMET01880 0.139 0.015 DBMET01881 0.169 0.009 DBMET01882 0.06 0.058 DBMET02185 0.084 0.038 DBMET02187 | DBMET01882 | |
| 0.203 | 0.054 | 0.243 | Mcl-1 antagonist | 0.232 0.042 DB00328 0.243 0.038 DBMET01880 0.216 0.048 DBMET01881 0.232 0.042 DBMET01882 0.123 0.121 DBMET02187 | DBMET01880 | |
| 0.263 | 0.132 | 0.495 | Calcium channel activator | 0.374 0.035 DB00328 0.215 0.191 DBMET01880 0.495 0.005 DBMET01881 0.374 0.035 DBMET01882 0.234 0.167 DBMET02186 | DBMET01881 | |
| 0.297 | 0.174 | 0.674 | Apoptosis agonist | 0.284 0.184 DB00328 0.31 0.165 DBMET01880 0.344 0.142 DBMET01881 0.284 0.184 DBMET01882 0.552 0.06 DBMET02185 0.674 0.035 DBMET02186 0.588 0.052 DBMET02187 | DBMET02186 | |
| 0.13 | 0.01 | 0.168 | Prostaglandin E2 antagonist | 0.168 0.007 DB00328 0.13 0.01 DBMET01880 0.073 0.022 DBMET01881 0.168 0.007 DBMET01882 | DBMET01882 | |
| 0.13 | 0.013 | 0.135 | Leukotriene synthesis inhibitor | 0.106 0.023 DB00328 0.135 0.012 DBMET01880 0.073 0.042 DBMET01881 0.106 0.023 DBMET01882 | DBMET01880 | |
| 0.206 | 0.09 | 0.308 | Hypolipemic | 0.169 0.119 DB00328 0.22 0.082 DBMET01880 0.17 0.118 DBMET01881 0.169 0.119 DBMET01882 0.308 0.046 DBMET02185 0.16 0.127 DBMET02186 0.191 0.101 DBMET02187 | DBMET02185 | |
| 0.152 | 0.037 | 0.182 | 5-Lipoxygenase inhibitor | 0.148 0.038 DB00328 0.182 0.028 DBMET01880 0.131 0.045 DBMET01881 0.148 0.038 DBMET01882 | DBMET01880 | |
| 0.126 | 0.014 | 0.126 | Leukotriene antagonist | 0.097 0.023 DB00328 0.124 0.014 DBMET01880 0.094 0.024 DBMET01881 0.097 0.023 DBMET01882 0.057 0.054 DBMET02187 | ||
| 0.137 | 0.033 | 0.162 | Gastric antisecretory | 0.115 0.048 DBMET01880 0.162 0.022 DBMET01881 | DBMET01881 | |
| 0.141 | 0.038 | 0.149 | Mucolytic | 0.12 0.054 DB00328 0.134 0.043 DBMET01880 0.149 0.033 DBMET01881 0.12 0.054 DBMET01882 0.112 0.062 DBMET02187 | DBMET01881 | |
| 0.146 | 0.042 | 0.201 | Cystathionine beta-synthase inhibitor | 0.176 0.031 DB00328 0.201 0.024 DBMET01880 0.158 0.037 DBMET01881 0.176 0.031 DBMET01882 0.093 0.085 DBMET02187 | DBMET01880 | |
| 0.121 | 0.025 | 0.151 | Macrophage migration inhibitory factor inhibitor | 0.151 0.015 DBMET01880 0.076 0.057 DBMET01881 | DBMET01880 | |
| 0.109 | 0.016 | 0.138 | Aldose reductase inhibitor | 0.119 0.014 DB00328 0.138 0.012 DBMET01880 0.095 0.019 DBMET01881 0.119 0.014 DBMET01882 0.049 0.04 DBMET02185 0.076 0.025 DBMET02187 | DBMET01880 | |
| 0.278 | 0.191 | 0.503 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 DB00328 0.298 0.167 DBMET01880 0.503 0.032 DBMET01881 0.308 0.156 DBMET01882 0.407 0.074 DBMET02186 0.261 0.213 DBMET02187 | DBMET01881 | |
| 0.114 | 0.028 | 0.125 | Interleukin 5 antagonist | 0.087 0.059 DB00328 0.125 0.021 DBMET01880 0.09 0.055 DBMET01881 0.087 0.059 DBMET01882 0.088 0.058 DBMET02185 | DBMET01880 | |
| 0.229 | 0.144 | 0.427 | Interleukin 2 agonist | 0.296 0.076 DB00328 0.279 0.09 DBMET01880 0.326 0.057 DBMET01881 0.296 0.076 DBMET01882 0.392 0.03 DBMET02185 0.42 0.022 DBMET02186 0.427 0.02 DBMET02187 | DBMET02187 | |
| 0.095 | 0.013 | 0.112 | Thromboxane antagonist | 0.075 0.023 DB00328 0.112 0.008 DBMET01880 0.051 0.04 DBMET01881 0.075 0.023 DBMET01882 | DBMET01880 | |
| 0.107 | 0.027 | 0.114 | Vanilloid agonist | 0.114 0.021 DBMET01880 | DBMET01880 | |
| 0.256 | 0.178 | 0.336 | Analgesic | 0.286 0.153 DB00328 0.336 0.116 DBMET01880 0.286 0.153 DBMET01882 | DBMET01880 | |
| 0.227 | 0.15 | 0.51 | Apoptosis antagonist | 0.252 0.126 DBMET01880 0.204 0.173 DBMET01881 0.399 0.039 DBMET02185 0.51 0.019 DBMET02186 0.349 0.056 DBMET02187 | DBMET02186 | |
| 0.089 | 0.015 | 0.089 | Peroxisome proliferator-activated receptor alpha agonist | 0.072 0.021 DB00328 0.06 0.026 DBMET01880 0.075 0.019 DBMET01881 0.072 0.021 DBMET01882 | ||
| 0.127 | 0.053 | 0.192 | Interleukin 8 antagonist | 0.192 0.015 DB00328 0.173 0.022 DBMET01880 0.179 0.019 DBMET01881 0.192 0.015 DBMET01882 | DBMET01882 | |
| 0.076 | 0.004 | 0.079 | Prostaglandin D2 agonist | 0.048 0.008 DB00328 0.079 0.004 DBMET01880 0.03 0.022 DBMET01881 0.048 0.008 DBMET01882 0.031 0.02 DBMET02187 | DBMET01880 | |
| 0.193 | 0.128 | 0.508 | 5 Hydroxytryptamine release stimulant | 0.188 0.132 DB00328 0.214 0.11 DBMET01880 0.508 0.026 DBMET01881 0.188 0.132 DBMET01882 0.345 0.058 DBMET02186 | DBMET01881 | |
| 0.117 | 0.052 | 0.195 | Multidrug resistance-associated protein 1 inhibitor | 0.135 0.034 DB00328 0.109 0.063 DBMET01880 0.1 0.078 DBMET01881 0.135 0.034 DBMET01882 0.131 0.037 DBMET02185 0.119 0.049 DBMET02186 0.195 0.012 DBMET02187 | DBMET02187 | |
| 0.078 | 0.016 | 0.091 | Thromboxane A2 antagonist | 0.06 0.028 DB00328 0.091 0.01 DBMET01880 0.043 0.042 DBMET01881 0.06 0.028 DBMET01882 | DBMET01880 | |
| 0.081 | 0.019 | 0.163 | Cannabinoid CB2 receptor antagonist | 0.163 0.007 DB00328 0.091 0.017 DBMET01880 0.163 0.007 DBMET01882 | DBMET01882 | |
| 0.221 | 0.161 | 0.375 | Sodium/bile acid cotransporter inhibitor | 0.308 0.072 DB00328 0.262 0.116 DBMET01880 0.375 0.026 DBMET01881 0.308 0.072 DBMET01882 | DBMET01881 | |
| 0.061 | 0.007 | 0.061 | Peroxisome proliferator-activated receptor alpha antagonist | 0.054 0.008 DB00328 0.043 0.009 DBMET01880 0.054 0.008 DBMET01882 | ||
| 0.158 | 0.105 | 0.185 | P-glycoprotein inhibitor | 0.154 0.11 DB00328 0.163 0.099 DBMET01881 0.154 0.11 DBMET01882 0.141 0.131 DBMET02186 0.185 0.075 DBMET02187 | DBMET02187 | |
| 0.077 | 0.025 | 0.077 | Nitric oxide donor | 0.077 0.025 DBMET01880 0.076 0.026 DBMET02185 0.065 0.04 DBMET02186 0.074 0.029 DBMET02187 | ||
| 0.074 | 0.022 | 0.095 | Calcium channel P-type blocker | 0.095 0.007 DB00328 0.064 0.042 DBMET01881 0.095 0.007 DBMET01882 | DBMET01882 | |
| 0.253 | 0.202 | 0.588 | Calcium channel L-type activator | 0.297 0.16 DB00328 0.332 0.131 DBMET01880 0.588 0.007 DBMET01881 0.297 0.16 DBMET01882 0.491 0.031 DBMET02186 | DBMET01881 | |
| 0.217 | 0.167 | 0.412 | Vasodilator, coronary | 0.292 0.094 DBMET01881 0.262 0.122 DBMET02185 0.412 0.031 DBMET02186 0.318 0.074 DBMET02187 | DBMET02186 | |
| 0.168 | 0.122 | 0.273 | Aryl hydrocarbon receptor agonist | 0.145 0.139 DBMET01880 0.273 0.07 DBMET01881 | DBMET01881 | |
| 0.065 | 0.02 | 0.072 | Leukotriene C antagonist | 0.069 0.015 DB00328 0.072 0.013 DBMET01880 0.071 0.013 DBMET01881 0.069 0.015 DBMET01882 | DBMET01880 | |
| 0.124 | 0.08 | 0.154 | Interleukin 4 antagonist | 0.154 0.047 DBMET01880 0.147 0.052 DBMET01881 0.137 0.063 DBMET02185 0.125 0.078 DBMET02186 0.12 0.086 DBMET02187 | DBMET01880 | |
| 0.168 | 0.125 | 0.46 | Aldehyde oxidase inhibitor | 0.206 0.102 DB00328 0.23 0.09 DBMET01880 0.46 0.038 DBMET01881 0.206 0.102 DBMET01882 | DBMET01881 | |
| 0.081 | 0.039 | 0.144 | Cannabinoid receptor antagonist | 0.144 0.016 DB00328 0.084 0.037 DBMET01880 0.144 0.016 DBMET01882 | DBMET01882 | |
| 0.112 | 0.072 | 0.18 | Cell adhesion inhibitor | 0.097 0.095 DB00328 0.102 0.086 DBMET01880 0.097 0.095 DBMET01882 0.125 0.062 DBMET02185 0.138 0.054 DBMET02186 0.18 0.031 DBMET02187 | DBMET02187 | |
| 0.045 | 0.005 | 0.081 | Thyroid hormone agonist | 0.043 0.005 DB00328 0.081 0.003 DBMET01880 0.08 0.003 DBMET01881 0.043 0.005 DBMET01882 | DBMET01880 | |
| 0.104 | 0.064 | 0.195 | Expectorant | 0.097 0.072 DBMET01880 0.128 0.046 DBMET01881 0.093 0.077 DBMET02185 0.154 0.034 DBMET02186 0.195 0.021 DBMET02187 | DBMET02187 | |
| 0.051 | 0.012 | 0.057 | Peroxisome proliferator-activated receptor delta agonist | 0.037 0.019 DB00328 0.032 0.025 DBMET01880 0.057 0.011 DBMET01881 0.037 0.019 DBMET01882 | DBMET01881 | |
| 0.081 | 0.043 | 0.111 | Cathepsin G inhibitor | 0.111 0.029 DB00328 0.098 0.034 DBMET01880 0.111 0.029 DBMET01882 | DBMET01882 | |
| 0.047 | 0.01 | 0.053 | Peroxisome proliferator-activated receptor delta antagonist | 0.053 0.009 DB00328 0.046 0.011 DBMET01880 0.052 0.009 DBMET01881 0.053 0.009 DBMET01882 | DBMET01882 | |
| 0.134 | 0.097 | 0.154 | Protein-tyrosine phosphatase inhibitor | 0.154 0.074 DBMET01880 | DBMET01880 | |
| 0.084 | 0.053 | 0.084 | Histamine H1 receptor antagonist | 0.079 0.059 DBMET01880 | ||
| 0.036 | 0.005 | 0.038 | Prostacyclin agonist | 0.038 0.005 DBMET01880 | DBMET01880 | |
| 0.067 | 0.037 | 0.102 | Cannabinoid CB1 receptor antagonist | 0.102 0.016 DB00328 0.078 0.029 DBMET01880 0.102 0.016 DBMET01882 | DBMET01882 | |
| 0.078 | 0.047 | 0.138 | GABA B receptor agonist | 0.111 0.01 DB00328 0.085 0.033 DBMET01880 0.138 0.005 DBMET01881 0.111 0.01 DBMET01882 | DBMET01881 | |
| 0.05 | 0.02 | 0.057 | Liver X receptor alpha agonist | 0.057 0.014 DB00328 0.057 0.014 DBMET01880 0.041 0.029 DBMET01881 0.057 0.014 DBMET01882 | DBMET01882 | |
| 0.059 | 0.029 | 0.067 | Thromboxane synthase inhibitor | 0.054 0.039 DB00328 0.067 0.02 DBMET01880 0.063 0.023 DBMET01881 0.054 0.039 DBMET01882 | DBMET01880 | |
| 0.124 | 0.095 | 0.146 | Farnesoid X receptor antagonist | 0.134 0.075 DB00328 0.146 0.058 DBMET01880 0.125 0.092 DBMET01881 0.134 0.075 DBMET01882 | DBMET01880 | |
| 0.091 | 0.063 | 0.118 | ABCA1 expression enhancer | 0.103 0.047 DB00328 0.092 0.061 DBMET01880 0.118 0.032 DBMET01881 0.103 0.047 DBMET01882 | DBMET01881 | |
| 0.039 | 0.011 | 0.053 | Prostaglandin EP4 antagonist | 0.053 0.008 DB00328 0.035 0.013 DBMET01880 0.053 0.008 DBMET01882 | DBMET01882 | |
| 0.113 | 0.087 | 0.194 | Tubulin antagonist | 0.142 0.062 DB00328 0.194 0.039 DBMET01881 0.142 0.062 DBMET01882 | DBMET01881 | |
| 0.069 | 0.043 | 0.081 | Bcl2 antagonist | 0.081 0.031 DB00328 0.081 0.031 DBMET01880 0.081 0.031 DBMET01882 | DBMET01882 | |
| 0.107 | 0.081 | 0.135 | Sphingosine 1-phosphate receptor 2 agonist | 0.135 0.037 DB00328 0.11 0.075 DBMET01880 0.135 0.037 DBMET01882 | DBMET01882 | |
| 0.042 | 0.019 | 0.048 | Leukotriene C4 antagonist | 0.046 0.014 DB00328 0.048 0.012 DBMET01880 0.047 0.013 DBMET01881 0.046 0.014 DBMET01882 | DBMET01880 | |
| 0.126 | 0.103 | 0.162 | Insulin secretagoues | 0.129 0.099 DBMET01880 0.162 0.063 DBMET01881 0.121 0.11 DBMET02185 0.142 0.083 DBMET02186 0.159 0.065 DBMET02187 | DBMET01881 | |
| 0.053 | 0.031 | 0.053 | Antiviral (Hepatitis D) | 0.051 0.034 DBMET01880 | ||
| 0.04 | 0.018 | 0.04 | Prostacyclin antagonist | 0.033 0.023 DBMET01880 | ||
| 0.055 | 0.034 | 0.056 | Leukotriene B4 antagonist | 0.056 0.034 DBMET01880 | DBMET01880 | |
| 0.023 | 0.005 | 0.027 | Thyroid hormone alpha agonist | 0.024 0.005 DB00328 0.027 0.004 DBMET01880 0.027 0.004 DBMET01881 0.024 0.005 DBMET01882 | DBMET01881 | |
| 0.055 | 0.037 | 0.078 | DNA helicase inhibitor | 0.076 0.013 DB00328 0.054 0.039 DBMET01880 0.078 0.012 DBMET01881 0.076 0.013 DBMET01882 | DBMET01881 | |
| 0.035 | 0.017 | 0.043 | Prostaglandin EP3 antagonist | 0.043 0.013 DB00328 0.035 0.018 DBMET01880 0.043 0.013 DBMET01882 | DBMET01882 | |
| 0.048 | 0.032 | 0.075 | Carnitine palmitoyltransferase 1B inhibitor | 0.075 0.009 DB00328 0.075 0.009 DBMET01881 0.075 0.009 DBMET01882 | DBMET01882 | |
| 0.109 | 0.095 | 0.139 | Sphingosine 1-phosphate receptor 4 antagonist | 0.139 0.045 DB00328 0.112 0.09 DBMET01881 0.139 0.045 DBMET01882 | DBMET01882 | |
| 0.088 | 0.075 | 0.141 | Xanthine oxidase inhibitor | 0.128 0.043 DBMET01880 0.098 0.062 DBMET01881 0.141 0.038 DBMET02186 0.093 0.067 DBMET02187 | DBMET02186 | |
| 0.019 | 0.008 | 0.037 | Thyroid hormone alpha antagonist | 0.026 0.005 DB00328 0.03 0.005 DBMET01880 0.037 0.005 DBMET01881 0.026 0.005 DBMET01882 | DBMET01881 | |
| 0.05 | 0.039 | 0.084 | Glucose-6-phosphate translocase inhibitor | 0.056 0.029 DB00328 0.048 0.042 DBMET01880 0.056 0.029 DBMET01882 0.071 0.015 DBMET02185 0.062 0.021 DBMET02186 0.084 0.01 DBMET02187 | DBMET02187 | |
| 0.063 | 0.051 | 0.135 | Sphingosine 1-phosphate receptor 4 agonist | 0.122 0.016 DB00328 0.075 0.04 DBMET01880 0.135 0.012 DBMET01881 0.122 0.016 DBMET01882 | DBMET01881 | |
| 0.114 | 0.103 | 0.14 | Vanilloid 1 agonist | 0.113 0.106 DBMET01880 0.14 0.05 DBMET01881 | DBMET01881 | |
| 0.09 | 0.081 | 0.138 | Mediator release inhibitor | 0.114 0.054 DBMET01880 0.138 0.035 DBMET01881 0.136 0.036 DBMET02186 | DBMET01881 | |
| 0.03 | 0.022 | 0.035 | Prostaglandin agonist | 0.035 0.017 DBMET01880 | DBMET01880 | |
| 0.193 | 0.184 | 0.481 | Vasodilator, peripheral | 0.481 0.032 DBMET01881 0.352 0.073 DBMET02186 | DBMET01881 | |
| 0.03 | 0.023 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 3A inhibitor | |||
| 0.03 | 0.023 | 0.03 | Elastase 2B inhibitor | |||
| 0.02 | 0.014 | 0.033 | Prostaglandin EP1 antagonist | 0.033 0.009 DB00328 0.02 0.014 DBMET01880 0.033 0.009 DBMET01882 | DBMET01882 | |
| 0.092 | 0.087 | 0.11 | Protein-tyrosine phosphatase 1B inhibitor | 0.11 0.069 DBMET01880 | DBMET01880 | |
| 0.008 | 0.007 | 0.036 | Thyroid hormone beta agonist | 0.01 0.005 DB00328 0.022 0.004 DBMET01880 0.036 0.003 DBMET01881 0.01 0.005 DBMET01882 | DBMET01881 | |
| 0.137 | 0.137 | 0.189 | Neurotensin receptor agonist | 0.151 0.1 DB00328 0.153 0.094 DBMET01880 0.189 0.042 DBMET01881 0.151 0.1 DBMET01882 | DBMET01881 | |
| 0.026 | 0.027 | 0.033 | Liver X receptor alpha antagonist | 0.033 0.014 DB00328 0.029 0.02 DBMET01880 0.031 0.017 DBMET01881 0.033 0.014 DBMET01882 | DBMET01882 | |
| 0.086 | 0.087 | 0.17 | Monophenol monooxygenase inhibitor | 0.129 0.056 DBMET01880 0.089 0.084 DBMET02185 0.122 0.06 DBMET02186 0.17 0.04 DBMET02187 | DBMET02187 | |
| 0.07 | 0.071 | 0.104 | Cell adhesion molecule inhibitor | 0.104 0.032 DBMET02187 | DBMET02187 | |
| 0.029 | 0.031 | 0.035 | Liver X receptor beta agonist | 0.035 0.02 DB00328 0.034 0.022 DBMET01880 0.035 0.02 DBMET01882 | DBMET01882 | |
| 0.084 | 0.089 | 0.127 | Bile acid receptor antagonist | 0.119 0.021 DB00328 0.096 0.057 DBMET01880 0.127 0.015 DBMET01881 0.119 0.021 DBMET01882 | DBMET01881 | |
| 0.029 | 0.034 | 0.046 | Carnitine palmitoyltransferase 1 inhibitor | 0.046 0.01 DB00328 0.038 0.017 DBMET01881 0.046 0.01 DBMET01882 | DBMET01882 | |
| 0.113 | 0.119 | 0.256 | Thrombolytic | 0.132 0.097 DBMET01880 0.169 0.069 DBMET01881 0.173 0.066 DBMET02185 0.256 0.032 DBMET02186 0.21 0.047 DBMET02187 | DBMET02186 | |
| 0.126 | 0.132 | 0.132 | Amyloid beta precursor protein antagonist | 0.132 0.124 DBMET01880 | DBMET01880 | |
| 0.136 | 0.142 | 0.219 | Catenin beta inhibitor | 0.166 0.073 DB00328 0.15 0.106 DBMET01880 0.219 0.021 DBMET01881 0.166 0.073 DBMET01882 | DBMET01881 | |
| 0.028 | 0.036 | 0.047 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 DB00328 0.038 0.018 DBMET01881 0.047 0.01 DBMET01882 | DBMET01882 | |
| 0.127 | 0.139 | 0.279 | Interleukin antagonist | 0.177 0.098 DB00328 0.178 0.097 DBMET01880 0.279 0.053 DBMET01881 0.177 0.098 DBMET01882 | DBMET01881 | |
| 0.133 | 0.146 | 0.174 | Phospholipase C inhibitor | 0.154 0.099 DB00328 0.174 0.068 DBMET01880 0.146 0.114 DBMET01881 0.154 0.099 DBMET01882 | DBMET01880 | |
| 0.047 | 0.06 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.03 DB00328 0.057 0.03 DBMET01881 0.057 0.03 DBMET01882 | DBMET01882 | |
| 0.02 | 0.033 | 0.037 | Liver X receptor beta antagonist | 0.037 0.014 DB00328 0.031 0.018 DBMET01880 0.037 0.014 DBMET01882 | DBMET01882 | |
| 0.169 | 0.184 | 0.212 | 12-Lipoxygenase inhibitor | 0.198 0.154 DB00328 0.209 0.141 DBMET01880 0.212 0.138 DBMET01881 0.198 0.154 DBMET01882 | DBMET01881 | |
| 0.027 | 0.043 | 0.054 | p53 inhibitor | 0.054 0.012 DB00328 0.033 0.028 DBMET01881 0.054 0.012 DBMET01882 | DBMET01882 | |
| 0.09 | 0.108 | 0.177 | TRPA1 agonist | 0.132 0.046 DB00328 0.109 0.072 DBMET01880 0.177 0.017 DBMET01881 0.132 0.046 DBMET01882 | DBMET01881 | |
| 0.09 | 0.11 | 0.172 | Photosensitizer | 0.097 0.096 DBMET01880 0.172 0.021 DBMET01881 0.138 0.039 DBMET02186 | DBMET01881 | |
| 0.128 | 0.148 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | 0.166 0.078 DB00328 0.155 0.093 DBMET01881 0.166 0.078 DBMET01882 | DBMET01882 | |
| 0.05 | 0.07 | 0.066 | Prostaglandin F2 alpha antagonist | 0.066 0.037 DB00328 0.058 0.05 DBMET01880 0.066 0.037 DBMET01882 | DBMET01882 | |
| 0.075 | 0.096 | 0.097 | Uric acid excretion stimulant | 0.085 0.073 DB00328 0.09 0.064 DBMET01880 0.085 0.073 DBMET01882 0.088 0.068 DBMET02186 0.097 0.056 DBMET02187 | DBMET02187 | |
| 0.05 | 0.071 | 0.061 | CDC25B inhibitor | 0.061 0.049 DBMET01880 | DBMET01880 | |
| 0.02 | 0.043 | 0.03 | Liver X receptor antagonist | 0.03 0.023 DB00328 0.03 0.023 DBMET01882 | DBMET01882 | |
| 0.113 | 0.138 | 0.127 | Dual specificity phosphatase 3 inhibitor | 0.127 0.119 DBMET01880 | DBMET01880 | |
| 0.191 | 0.218 | 0.239 | Antiobesity | 0.239 0.167 DB00328 0.209 0.198 DBMET01880 0.239 0.167 DBMET01882 | DBMET01882 | |
| 0.023 | 0.052 | 0.043 | Farnesoid X receptor agonist | 0.043 0.02 DB00328 0.043 0.02 DBMET01882 | DBMET01882 | |
| 0.124 | 0.154 | 0.228 | Lipocortins synthesis antagonist | 0.134 0.132 DB00328 0.228 0.041 DBMET01881 0.134 0.132 DBMET01882 0.161 0.091 DBMET02186 | DBMET01881 | |
| 0.034 | 0.065 | 0.045 | Plasminogen activator inhibitor antagonist | 0.045 0.04 DBMET01881 | DBMET01881 | |
| 0.118 | 0.149 | 0.34 | Psychostimulant | 0.21 0.075 DB00328 0.34 0.034 DBMET01881 0.21 0.075 DBMET01882 0.163 0.105 DBMET02186 | DBMET01881 | |
| 0.018 | 0.05 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.02 DB00328 0.028 0.02 DBMET01882 | DBMET01882 | |
| 0.118 | 0.151 | 0.227 | Pyruvate kinase inhibitor | 0.136 0.129 DBMET01880 0.227 0.068 DBMET01881 | DBMET01881 | |
| 0.022 | 0.056 | 0.1 | NMDA receptor subunit 3A antagonist | 0.066 0.015 DBMET01880 0.1 0.008 DBMET01881 | DBMET01881 | |
| 0.116 | 0.151 | 0.275 | DNA methyltransferase I inhibitor | 0.13 0.129 DB00328 0.275 0.036 DBMET01881 0.13 0.129 DBMET01882 0.18 0.08 DBMET02186 | DBMET01881 | |
| 0.046 | 0.082 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 DBMET01881 | DBMET01881 | |
| 0.033 | 0.07 | 0.065 | Beta tubulin antagonist | 0.05 0.047 DB00328 0.065 0.037 DBMET01881 0.05 0.047 DBMET01882 | DBMET01881 | |
| 0.132 | 0.17 | 0.365 | Antiamyloidogenic | 0.227 0.083 DB00328 0.209 0.093 DBMET01881 0.227 0.083 DBMET01882 0.206 0.096 DBMET02186 0.365 0.036 DBMET02187 | DBMET02187 | |
| 0.027 | 0.067 | 0.123 | NMDA receptor subunit 3B antagonist | 0.044 0.03 DB00328 0.058 0.02 DBMET01880 0.123 0.008 DBMET01881 0.044 0.03 DBMET01882 | DBMET01881 | |
| 0.079 | 0.12 | 0.15 | Cholesterol synthesis inhibitor | 0.132 0.055 DB00328 0.15 0.045 DBMET01881 0.132 0.055 DBMET01882 | DBMET01881 | |
| 0.095 | 0.136 | 0.121 | Antibacterial (Helicobacter pylori) | 0.121 0.08 DBMET01881 | DBMET01881 | |
| 0.067 | 0.109 | 0.075 | MAP kinase 7 inhibitor | 0.075 0.064 DB00328 0.075 0.064 DBMET01882 | DBMET01882 | |
| 0.047 | 0.089 | 0.066 | Lipocortins synthesis agonist | 0.063 0.031 DBMET02185 0.066 0.025 DBMET02186 0.058 0.04 DBMET02187 | DBMET02186 | |
| 0.064 | 0.112 | 0.079 | Factor XII inhibitor | 0.079 0.068 DB00328 0.079 0.068 DBMET01882 | DBMET01882 | |
| 0.132 | 0.183 | 0.337 | Spasmolytic | 0.206 0.114 DBMET01881 0.175 0.141 DBMET02185 0.337 0.057 DBMET02186 | DBMET02186 | |
| 0.134 | 0.186 | 0.463 | Antioxidant | 0.186 0.126 DBMET01880 0.209 0.108 DBMET01881 0.342 0.048 DBMET02185 0.463 0.025 DBMET02186 0.453 0.026 DBMET02187 | DBMET02186 | |
| 0.051 | 0.103 | 0.065 | HIV-1 integrase inhibitor | 0.065 0.055 DBMET01880 | DBMET01880 | |
| 0.1 | 0.156 | 0.196 | Hexokinase inhibitor | 0.122 0.115 DBMET01880 0.196 0.038 DBMET02187 | DBMET02187 | |
| 0.036 | 0.093 | 0.062 | Androgen agonist | 0.062 0.038 DB00328 0.059 0.042 DBMET01880 0.062 0.038 DBMET01881 0.062 0.038 DBMET01882 | DBMET01882 | |
| 0.176 | 0.235 | 0.516 | Histamine release inhibitor | 0.266 0.144 DB00328 0.233 0.169 DBMET01880 0.516 0.024 DBMET01881 0.266 0.144 DBMET01882 0.456 0.047 DBMET02186 0.293 0.127 DBMET02187 | DBMET01881 | |
| 0.069 | 0.128 | 0.085 | Interleukin 1 beta converting enzyme inhibitor | 0.085 0.08 DBMET01881 | DBMET01881 | |
| 0.011 | 0.072 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.015 DBMET01881 | DBMET01881 | |
| 0.125 | 0.185 | 0.412 | Free radical scavenger | 0.172 0.122 DBMET01880 0.201 0.097 DBMET01881 0.282 0.057 DBMET02185 0.412 0.027 DBMET02186 0.389 0.031 DBMET02187 | DBMET02186 | |
| 0.006 | 0.067 | 0.018 | Endothelin B receptor antagonist | 0.018 0.013 DBMET01881 | DBMET01881 | |
| 0.018 | 0.08 | 0.059 | Melatonin 1 agonist | 0.059 0.007 DBMET01881 0.031 0.026 DBMET02186 | DBMET01881 | |
| 0.134 | 0.197 | 0.204 | Cardiotonic | 0.204 0.115 DBMET01881 | DBMET01881 | |
| 0.021 | 0.084 | 0.031 | Estrogen-related receptor beta antagonist | 0.031 0.026 DBMET01880 | DBMET01880 | |
| 0.011 | 0.074 | 0.029 | Endothelin receptor antagonist | 0.029 0.018 DBMET01881 | DBMET01881 | |
| 0.054 | 0.118 | 0.078 | MDM2 inhibitor | 0.074 0.03 DB00328 0.078 0.022 DBMET01881 0.074 0.03 DBMET01882 | DBMET01881 | |
| 0.063 | 0.127 | 0.122 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.101 0.053 DB00328 0.122 0.038 DBMET01881 0.101 0.053 DBMET01882 0.091 0.064 DBMET02186 0.095 0.059 DBMET02187 | DBMET01881 | |
| 0.051 | 0.116 | 0.067 | Glycine receptor agonist | 0.067 0.062 DB00328 0.067 0.062 DBMET01882 | DBMET01882 | |
| 0.009 | 0.075 | 0.055 | NMDA receptor glycine site antagonist | 0.055 0.005 DBMET01881 | DBMET01881 | |
| 0.081 | 0.148 | 0.125 | Estrogen antagonist | 0.125 0.046 DBMET01880 | DBMET01880 | |
| 0.016 | 0.084 | 0.061 | Melatonin 2 agonist | 0.061 0.008 DBMET01881 0.039 0.016 DBMET02186 | DBMET01881 | |
| 0.076 | 0.144 | 0.179 | DOPA decarboxylase inhibitor | 0.123 0.042 DB00328 0.118 0.047 DBMET01880 0.179 0.01 DBMET01881 0.123 0.042 DBMET01882 | DBMET01881 | |
| 0.034 | 0.102 | 0.104 | Potassium channel Kv1.5 blocker | 0.052 0.046 DB00328 0.104 0.017 DBMET01881 0.052 0.046 DBMET01882 | DBMET01881 | |
| 0.087 | 0.155 | 0.153 | Protein kinase stimulant | 0.122 0.09 DBMET01881 0.153 0.066 DBMET02186 | DBMET02186 | |
| 0.031 | 0.1 | 0.276 | Selectin antagonist | 0.208 0.01 DBMET02185 0.276 0.007 DBMET02186 0.275 0.007 DBMET02187 | DBMET02186 | |
| 0.026 | 0.095 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.029 DBMET01881 | DBMET01881 | |
| 0.017 | 0.088 | 0.051 | Urate transporter 1 inhibitor | 0.051 0.018 DB00328 0.051 0.018 DBMET01882 | DBMET01882 | |
| 0.151 | 0.223 | 0.305 | Gastrin inhibitor | 0.255 0.074 DB00328 0.305 0.03 DBMET01881 0.255 0.074 DBMET01882 | DBMET01881 | |
| 0.101 | 0.174 | 0.3 | Nitric oxide antagonist | 0.13 0.118 DBMET01881 0.232 0.057 DBMET02185 0.3 0.04 DBMET02186 0.293 0.042 DBMET02187 | DBMET02186 | |
| 0.044 | 0.12 | 0.079 | Potassium channel large-conductance Ca-activated activator | 0.078 0.036 DB00328 0.079 0.036 DBMET01881 0.078 0.036 DBMET01882 | DBMET01881 | |
| 0.119 | 0.197 | 0.14 | Heat shock protein 70 antagonist | 0.135 0.096 DB00328 0.14 0.076 DBMET01881 0.135 0.096 DBMET01882 | DBMET01881 | |
| 0.048 | 0.127 | 0.169 | Potassium channel (Ca-activated) activator | 0.137 0.032 DB00328 0.169 0.022 DBMET01881 0.137 0.032 DBMET01882 | DBMET01881 | |
| 0.014 | 0.094 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DBMET01881 0.022 0.015 DBMET02186 | DBMET02186 | |
| 0.076 | 0.156 | 0.108 | Aldehyde dehydrogenase inhibitor | 0.108 0.085 DBMET01880 | DBMET01880 | |
| 0.103 | 0.184 | 0.22 | Interferon gamma antagonist | 0.171 0.057 DBMET01881 0.139 0.095 DBMET02185 0.22 0.035 DBMET02186 0.175 0.053 DBMET02187 | DBMET02186 | |
| 0.015 | 0.097 | 0.045 | Melatonin agonist | 0.045 0.011 DBMET01881 | DBMET01881 | |
| 0.156 | 0.238 | 0.35 | Tyrosine 3 hydroxylase inhibitor | 0.218 0.106 DBMET01880 0.35 0.016 DBMET01881 | DBMET01881 | |
| 0.013 | 0.1 | 0.053 | Free fatty acid receptor 1 antagonist | 0.033 0.024 DB00328 0.053 0.008 DBMET01881 0.033 0.024 DBMET01882 | DBMET01881 | |
| 0.097 | 0.186 | 0.241 | GABA C receptor rho-2 antagonist | 0.135 0.096 DB00328 0.241 0.014 DBMET01881 0.135 0.096 DBMET01882 | DBMET01881 | |
| 0.154 | 0.243 | 0.28 | Insulysin inhibitor | 0.233 0.114 DB00328 0.209 0.144 DBMET01880 0.28 0.071 DBMET01881 0.233 0.114 DBMET01882 | DBMET01881 | |
| 0.1 | 0.194 | 0.257 | DNA methylase inhibitor | 0.257 0.044 DBMET01881 0.231 0.059 DBMET02186 0.158 0.111 DBMET02187 | DBMET01881 | |
| 0.155 | 0.249 | 0.435 | Immunosuppressant | 0.353 0.085 DBMET02185 0.407 0.06 DBMET02186 0.435 0.052 DBMET02187 | DBMET02187 | |
| 0.051 | 0.145 | 0.075 | Antineoplastic alkaloid | 0.075 0.072 DBMET01881 | DBMET01881 | |
| 0.083 | 0.177 | 0.144 | Anticoagulant | 0.122 0.109 DBMET02186 0.144 0.086 DBMET02187 | DBMET02187 | |
| 0.059 | 0.155 | 0.097 | M18 aspartyl aminopeptidase inhibitor | 0.097 0.096 DBMET01880 | DBMET01880 | |
| 0.064 | 0.162 | 0.109 | Interleukin 1b antagonist | 0.109 0.071 DBMET01881 | DBMET01881 | |
| 0.009 | 0.107 | 0.026 | Melatonin antagonist | 0.026 0.024 DBMET01881 | DBMET01881 | |
| 0.03 | 0.13 | 0.066 | Prostaglandin-E synthase inhibitor | 0.066 0.054 DB00328 0.063 0.059 DBMET01881 0.066 0.054 DBMET01882 | DBMET01882 | |
| 0.022 | 0.123 | 0.099 | NMDA 2C receptor antagonist | 0.055 0.053 DBMET01880 0.099 0.016 DBMET01881 | DBMET01881 | |
| 0.101 | 0.203 | 0.178 | CF transmembrane conductance regulator agonist | 0.178 0.038 DBMET01881 0.175 0.041 DBMET02186 0.128 0.122 DBMET02187 | DBMET01881 | |
| 0.156 | 0.258 | 0.486 | Alpha-glucosidase inhibitor | 0.382 0.122 DBMET02186 0.486 0.085 DBMET02187 | DBMET02187 | |
| 0.043 | 0.147 | 0.144 | NMDA receptor antagonist | 0.1 0.047 DBMET01880 0.144 0.026 DBMET01881 | DBMET01881 | |
| 0.025 | 0.13 | 0.048 | Kainate receptor agonist | 0.042 0.028 DB00328 0.048 0.017 DBMET01881 0.042 0.028 DBMET01882 | DBMET01881 | |
| 0.14 | 0.248 | 0.25 | Nitric-oxide synthase stimulant | 0.174 0.143 DB00328 0.25 0.032 DBMET01881 0.174 0.143 DBMET01882 0.221 0.059 DBMET02186 | DBMET01881 | |
| 0.093 | 0.207 | 0.341 | Hepatoprotectant | 0.157 0.103 DBMET01881 0.271 0.038 DBMET02185 0.341 0.02 DBMET02186 0.299 0.03 DBMET02187 | DBMET02186 | |
| 0.095 | 0.212 | 0.13 | Interleukin 6 antagonist | 0.13 0.124 DBMET01881 | DBMET01881 | |
| 0.037 | 0.156 | 0.073 | Adenine nucleotide translocase inhibitor | 0.056 0.036 DBMET02185 0.065 0.02 DBMET02186 0.073 0.013 DBMET02187 | DBMET02187 | |
| 0.01 | 0.132 | 0.05 | Kainate receptor antagonist | 0.05 0.021 DBMET01881 | DBMET01881 | |
| 0.021 | 0.144 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.059 0.024 DBMET01881 | DBMET01881 | |
| 0.108 | 0.232 | 0.37 | Vasodilator | 0.215 0.093 DBMET01881 0.217 0.092 DBMET02185 0.37 0.028 DBMET02186 0.238 0.076 DBMET02187 | DBMET02186 | |
| 0.05 | 0.177 | 0.109 | ATPase (Vacuolar H+) inhibitor | 0.098 0.043 DBMET01881 0.109 0.029 DBMET02186 0.083 0.072 DBMET02187 | DBMET02186 | |
| 0.017 | 0.145 | 0.09 | Melatonin receptor 1A agonist | 0.09 0.004 DBMET01881 | DBMET01881 | |
| 0.147 | 0.274 | 0.347 | 15-Lipoxygenase inhibitor | 0.347 0.101 DBMET01881 | DBMET01881 | |
| 0.054 | 0.184 | 0.106 | Estrogen receptor beta antagonist | 0.106 0.053 DBMET01880 | DBMET01880 | |
| 0.057 | 0.19 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.052 DBMET01881 | DBMET01881 | |
| 0.061 | 0.193 | 0.165 | Toll-Like receptor 4 antagonist | 0.127 0.037 DBMET02185 0.151 0.02 DBMET02186 0.165 0.014 DBMET02187 | DBMET02187 | |
| 0.016 | 0.15 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | 0.064 0.015 DBMET01881 | DBMET01881 | |
| 0.128 | 0.263 | 0.284 | RNA-directed DNA polymerase inhibitor | 0.251 0.048 DBMET01881 0.284 0.035 DBMET02186 | DBMET02186 | |
| 0.017 | 0.155 | 0.055 | Alpha tubulin antagonist | 0.055 0.035 DBMET01881 | DBMET01881 | |
| 0.02 | 0.159 | 0.108 | NMDA receptor glycine site agonist | 0.108 0.013 DBMET01881 | DBMET01881 | |
| 0.065 | 0.203 | 0.161 | Toll-Like receptor 2 antagonist | 0.161 0.045 DBMET01881 | DBMET01881 | |
| 0.026 | 0.165 | 0.138 | Catalase inhibitor | 0.138 0.029 DBMET01881 | DBMET01881 | |
| 0.088 | 0.228 | 0.158 | Anticonvulsant | 0.158 0.12 DBMET01881 | DBMET01881 | |
| 0.042 | 0.182 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.071 DBMET01881 | DBMET01881 | |
| 0.004 | 0.144 | 0.012 | Melatonin 2 antagonist | 0.012 0.008 DBMET01881 | DBMET01881 | |
| 0.061 | 0.203 | 0.124 | Interleukin 12 antagonist | 0.124 0.025 DBMET01881 0.105 0.046 DBMET02186 | DBMET01881 | |
| 0.048 | 0.19 | 0.088 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET01881 | DBMET01881 | |
| 0.018 | 0.161 | 0.05 | Mineralocorticoid receptor antagonist | 0.05 0.03 DBMET01881 | DBMET01881 | |
| 0.087 | 0.231 | 0.199 | Melanin inhibitor | 0.171 0.058 DBMET01881 0.199 0.041 DBMET02186 0.134 0.107 DBMET02187 | DBMET02186 | |
| 0.023 | 0.172 | 0.045 | GABA B receptor antagonist | 0.045 0.026 DBMET01881 | DBMET01881 | |
| 0.037 | 0.187 | 0.195 | Topoisomerase I inhibitor | 0.105 0.066 DBMET02185 0.195 0.028 DBMET02186 0.171 0.034 DBMET02187 | DBMET02186 | |
| 0.057 | 0.207 | 0.086 | Estrogen-related receptor beta agonist | 0.086 0.049 DBMET01881 | DBMET01881 | |
| 0.029 | 0.181 | 0.083 | Beta adrenoreceptor antagonist | 0.083 0.025 DBMET01881 | DBMET01881 | |
| 0.051 | 0.203 | 0.115 | DNA polymerase I inhibitor | 0.115 0.072 DBMET02186 | DBMET02186 | |
| 0.007 | 0.16 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET02186 0.03 0.013 DBMET02187 | DBMET02187 | |
| 0.03 | 0.184 | 0.119 | NMDA receptor agonist | 0.119 0.013 DBMET01881 | DBMET01881 | |
| 0.05 | 0.204 | 0.157 | NADH dehydrogenase inhibitor | 0.091 0.055 DBMET01881 0.157 0.016 DBMET02186 0.121 0.028 DBMET02187 | DBMET02186 | |
| 0.016 | 0.172 | 0.033 | Toll-Like receptor 4 agonist | 0.025 0.022 DBMET02185 0.033 0.009 DBMET02186 0.028 0.015 DBMET02187 | DBMET02186 | |
| 0.04 | 0.199 | 0.139 | Platelet activating factor antagonist | 0.139 0.051 DBMET01881 | DBMET01881 | |
| 0.027 | 0.186 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.043 DBMET01881 | DBMET01881 | |
| 0.005 | 0.17 | 0.03 | Progesterone antagonist | 0.03 0.028 DBMET01881 | DBMET01881 | |
| 0.035 | 0.2 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.043 DBMET01881 | DBMET01881 | |
| 0.046 | 0.213 | 0.107 | Triose-phosphate isomerase inhibitor | 0.094 0.054 DBMET01881 0.107 0.041 DBMET02186 | DBMET02186 | |
| 0.049 | 0.217 | 0.244 | Alkylator | 0.105 0.083 DBMET01881 0.104 0.084 DBMET02185 0.244 0.017 DBMET02186 0.13 0.059 DBMET02187 | DBMET02186 | |
| 0.144 | 0.317 | 0.254 | 5 Hydroxytryptamine uptake stimulant | 0.209 0.135 DB00328 0.254 0.077 DBMET01881 0.209 0.135 DBMET01882 | DBMET01881 | |
| 0.026 | 0.203 | 0.16 | Platelet growth factor antagonist | 0.16 0.016 DBMET01881 | DBMET01881 | |
| 0.077 | 0.254 | 0.28 | Interleukin agonist | 0.203 0.118 DB00328 0.251 0.078 DBMET01881 0.203 0.118 DBMET01882 0.24 0.086 DBMET02186 0.28 0.059 DBMET02187 | DBMET02187 | |
| 0.019 | 0.197 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET01881 | DBMET01881 | |
| 0.108 | 0.287 | 0.138 | Ca2+-transporting ATPase inhibitor | 0.138 0.081 DBMET01881 0.131 0.114 DBMET02186 | DBMET01881 | |
| 0.12 | 0.3 | 0.175 | Neuropeptide Y2 antagonist | 0.175 0.172 DB00328 0.175 0.172 DBMET01882 | DBMET01882 | |
| 0.032 | 0.212 | 0.065 | Calcium channel L-type blocker | 0.065 0.06 DBMET01881 | DBMET01881 | |
| 0.048 | 0.228 | 0.174 | AMP-activated protein kinase stimulant | 0.115 0.053 DBMET01881 0.09 0.086 DBMET02185 0.157 0.024 DBMET02186 0.174 0.016 DBMET02187 | DBMET02187 | |
| 0.074 | 0.254 | 0.133 | Neuropeptide Y1 antagonist | 0.133 0.094 DBMET01881 | DBMET01881 | |
| 0.05 | 0.231 | 0.117 | Granulocyte macrophage colony stimulating factor agonist | 0.117 0.018 DBMET01881 | DBMET01881 | |
| 0.049 | 0.232 | 0.216 | Lipid peroxidase inhibitor | 0.142 0.074 DBMET02185 0.21 0.038 DBMET02186 0.216 0.035 DBMET02187 | DBMET02187 | |
| 0.057 | 0.246 | 0.087 | Glutamate release inhibitor | 0.087 0.07 DBMET01881 | DBMET01881 | |
| 0.058 | 0.247 | 0.132 | Amyloid beta aggregation inhibitor | 0.132 0.123 DBMET02186 | DBMET02186 | |
| 0.026 | 0.217 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.044 DBMET01881 | DBMET01881 | |
| 0.048 | 0.242 | 0.104 | Bone formation stimulant | 0.104 0.102 DBMET01881 | DBMET01881 | |
| 0.173 | 0.367 | 0.517 | Caspase 9 stimulant | 0.296 0.198 DB00328 0.517 0.054 DBMET01881 0.296 0.198 DBMET01882 0.474 0.071 DBMET02186 0.387 0.119 DBMET02187 | DBMET01881 | |
| 0.039 | 0.234 | 0.103 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 DBMET01881 | DBMET01881 | |
| 0.082 | 0.279 | 0.126 | Pregnane X receptor agonist | 0.126 0.112 DB00328 0.126 0.112 DBMET01882 | DBMET01882 | |
| 0.019 | 0.222 | 0.089 | Phosphodiesterase 4D inhibitor | 0.089 0.042 DBMET01881 | DBMET01881 | |
| 0.023 | 0.226 | 0.099 | Heparanase inhibitor | 0.059 0.024 DBMET01881 0.066 0.015 DBMET02185 0.099 0.004 DBMET02186 0.074 0.009 DBMET02187 | DBMET02186 | |
| 0.051 | 0.255 | 0.138 | Microtubule formation inhibitor | 0.111 0.072 DBMET01881 0.138 0.044 DBMET02186 0.099 0.092 DBMET02187 | DBMET02186 | |
| 0.033 | 0.24 | 0.064 | Ryanodine receptor antagonist | 0.064 0.027 DBMET01881 | DBMET01881 | |
| 0.067 | 0.28 | 0.155 | Antimitotic | 0.155 0.116 DBMET01881 | DBMET01881 | |
| 0.008 | 0.222 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 DBMET02186 0.026 0.016 DBMET02187 | DBMET02186 | |
| 0.071 | 0.285 | 0.169 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.169 0.122 DBMET01881 | DBMET01881 | |
| 0.025 | 0.245 | 0.124 | Calcium antagonist | 0.124 0.033 DBMET01881 | DBMET01881 | |
| 0.016 | 0.237 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.057 0.033 DBMET02185 0.078 0.02 DBMET02186 0.077 0.021 DBMET02187 | DBMET02186 | |
| 0.028 | 0.25 | 0.073 | Glutamate (mGluR7) antagonist | 0.073 0.037 DBMET01881 | DBMET01881 | |
| 0.081 | 0.306 | 0.162 | Neurotrophic factor enhancer | 0.162 0.121 DBMET01881 | DBMET01881 | |
| 0.085 | 0.31 | 0.225 | ATPase inhibitor | 0.225 0.022 DBMET01881 0.204 0.034 DBMET02186 0.154 0.095 DBMET02187 | DBMET01881 | |
| 0.009 | 0.235 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 DBMET01881 | DBMET01881 | |
| 0.123 | 0.349 | 0.326 | GABA C receptor rho-3 antagonist | 0.251 0.154 DBMET01880 0.326 0.099 DBMET01881 | DBMET01881 | |
| 0.021 | 0.247 | 0.112 | Platelet activating factor beta antagonist | 0.112 0.055 DBMET01881 | DBMET01881 | |
| 0.022 | 0.249 | 0.076 | Androgen antagonist | 0.076 0.07 DBMET01881 | DBMET01881 | |
| 0.058 | 0.285 | 0.207 | Cell wall synthesis inhibitor | 0.207 0.027 DBMET02186 0.171 0.047 DBMET02187 | DBMET02186 | |
| 0.024 | 0.252 | 0.093 | Topoisomerase II alpha inhibitor | 0.093 0.044 DBMET02186 0.077 0.055 DBMET02187 | DBMET02186 | |
| 0.067 | 0.296 | 0.354 | Immunostimulant | 0.187 0.128 DBMET02185 0.349 0.065 DBMET02186 0.354 0.063 DBMET02187 | DBMET02187 | |
| 0.024 | 0.254 | 0.08 | Fibroblast growth factor 1 antagonist | 0.08 0.074 DBMET01881 | DBMET01881 | |
| 0.016 | 0.25 | 0.061 | Phosphodiesterase 4B inhibitor | 0.061 0.056 DBMET01881 | DBMET01881 | |
| 0.033 | 0.273 | 0.08 | Keratolytic | 0.08 0.049 DBMET01881 | DBMET01881 | |
| 0.042 | 0.282 | 0.106 | Carbonic anhydrase III inhibitor | 0.106 0.056 DBMET01881 | DBMET01881 | |
| 0.066 | 0.308 | 0.12 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.097 DBMET01881 | DBMET01881 | |
| 0.034 | 0.281 | 0.107 | M17 leucyl aminopeptidase inhibitor | 0.107 0.092 DBMET01881 | DBMET01881 | |
| 0.031 | 0.279 | 0.107 | Glutamate receptor antagonist | 0.107 0.088 DBMET01881 | DBMET01881 | |
| 0.018 | 0.266 | 0.061 | Phosphodiesterase III inhibitor | 0.061 0.051 DBMET01881 | DBMET01881 | |
| 0.011 | 0.264 | 0.138 | Antineoplastic antibiotic | 0.074 0.061 DBMET02185 0.138 0.034 DBMET02186 0.097 0.048 DBMET02187 | DBMET02186 | |
| 0.016 | 0.27 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET01881 | DBMET01881 | |
| 0.078 | 0.332 | 0.337 | DNA damaging | 0.226 0.095 DBMET01881 0.337 0.045 DBMET02186 | DBMET02186 | |
| 0.039 | 0.294 | 0.082 | Thioredoxin inhibitor | 0.082 0.077 DBMET02186 | DBMET02186 | |
| 0.013 | 0.271 | 0.066 | Phosphofructokinase-1 inhibitor | 0.066 0.051 DBMET02186 | DBMET02186 | |
| 0.025 | 0.286 | 0.136 | Glycine receptor antagonist | 0.114 0.022 DBMET01881 0.136 0.011 DBMET02186 | DBMET02186 | |
| 0.036 | 0.298 | 0.37 | Beta glucuronidase inhibitor | 0.128 0.039 DBMET01881 0.093 0.082 DBMET02185 0.37 0.004 DBMET02186 0.19 0.014 DBMET02187 | DBMET02186 | |
| 0.117 | 0.379 | 0.247 | Caspase 3 stimulant | 0.205 0.162 DBMET01881 0.247 0.115 DBMET02186 0.233 0.128 DBMET02187 | DBMET02186 | |
| 0.05 | 0.317 | 0.232 | Adenylate kinase inhibitor | 0.232 0.011 DBMET01881 | DBMET01881 | |
| 0.036 | 0.306 | 0.188 | GABA C receptor rho-1 antagonist | 0.188 0.01 DBMET01881 | DBMET01881 | |
| 0.017 | 0.291 | 0.086 | Glutamate decarboxylase inhibitor | 0.086 0.039 DBMET01881 | DBMET01881 | |
| 0.025 | 0.301 | 0.096 | Interferon agonist | 0.096 0.032 DBMET01881 0.077 0.057 DBMET02186 | DBMET01881 | |
| 0.106 | 0.385 | 0.334 | Peptidyltransferase inhibitor | 0.171 0.145 DBMET01881 0.273 0.036 DBMET02185 0.334 0.015 DBMET02186 0.295 0.026 DBMET02187 | DBMET02186 | |
| 0.016 | 0.298 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | 0.071 0.045 DBMET01881 | DBMET01881 | |
| 0.063 | 0.353 | 0.15 | Adenylate cyclase stimulant | 0.15 0.062 DBMET01881 | DBMET01881 | |
| 0.063 | 0.358 | 0.134 | Growth hormone agonist | 0.134 0.102 DBMET01881 | DBMET01881 | |
| 0.022 | 0.319 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.069 DBMET01881 | DBMET01881 | |
| 0.036 | 0.333 | 0.132 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.07 DBMET01881 0.132 0.067 DBMET02186 | DBMET02186 | |
| 0.042 | 0.339 | 0.515 | Angiogenesis stimulant | 0.378 0.026 DBMET02185 0.515 0.011 DBMET02186 0.418 0.019 DBMET02187 | DBMET02186 | |
| 0.029 | 0.326 | 0.166 | Ferrochelatase inhibitor | 0.166 0.032 DBMET01881 | DBMET01881 | |
| 0.005 | 0.305 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 DBMET02186 | DBMET02186 | |
| 0.072 | 0.379 | 0.141 | Sphingosine 1-phosphate receptor 5 antagonist | 0.141 0.077 DBMET01881 | DBMET01881 | |
| 0.065 | 0.372 | 0.307 | 5 Hydroxytryptamine 1E antagonist | 0.307 0.026 DBMET01881 | DBMET01881 | |
| 0.06 | 0.367 | 0.306 | Tumour necrosis factor alpha release inhibitor | 0.236 0.082 DBMET02186 0.306 0.051 DBMET02187 | DBMET02187 | |
| 0.074 | 0.385 | 0.271 | Superoxide dismutase inhibitor | 0.271 0.062 DBMET01881 | DBMET01881 | |
| 0.041 | 0.352 | 0.111 | Transcription factor NF kappa B stimulant | 0.084 0.06 DBMET02185 0.111 0.03 DBMET02186 0.093 0.047 DBMET02187 | DBMET02186 | |
| 0.025 | 0.336 | 0.091 | DNA intercalator | 0.091 0.084 DBMET02186 | DBMET02186 | |
| 0.014 | 0.332 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.047 DBMET02186 | DBMET02186 | |
| 0.044 | 0.364 | 0.31 | Peroxidase inhibitor | 0.31 0.035 DBMET01881 | DBMET01881 | |
| 0.023 | 0.344 | 0.07 | Interferon inducer | 0.07 0.035 DBMET01881 | DBMET01881 | |
| 0.036 | 0.378 | 0.151 | Adenylate cyclase inhibitor | 0.151 0.044 DBMET01881 | DBMET01881 | |
| 0.013 | 0.358 | 0.096 | Porphobilinogen synthase inhibitor | 0.096 0.038 DBMET01881 | DBMET01881 | |
| 0.078 | 0.423 | 0.272 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.272 0.033 DBMET01881 0.155 0.137 DBMET02186 | DBMET01881 | |
| 0.016 | 0.366 | 0.049 | Aldosterone antagonist | 0.049 0.031 DBMET01881 | DBMET01881 | |
| 0.037 | 0.397 | 0.097 | Carbonic anhydrase XV inhibitor | 0.097 0.072 DBMET01881 | DBMET01881 | |
| 0.025 | 0.387 | 0.074 | Carbonic anhydrase VI inhibitor | 0.074 0.066 DBMET01881 | DBMET01881 | |
| 0.033 | 0.4 | 0.097 | Nav1.4 sodium channel blocker | 0.097 0.081 DBMET01881 | DBMET01881 | |
| 0.022 | 0.39 | 0.146 | Topoisomerase II inhibitor | 0.146 0.052 DBMET02186 0.106 0.08 DBMET02187 | DBMET02186 | |
| 0.052 | 0.422 | 0.186 | NOS3 expression enhancer | 0.123 0.11 DBMET02185 0.186 0.047 DBMET02186 0.171 0.055 DBMET02187 | DBMET02186 | |
| 0.021 | 0.419 | 0.158 | GABA C receptor antagonist | 0.158 0.026 DBMET01881 | DBMET01881 | |
| 0.022 | 0.429 | 0.159 | 5 Hydroxytryptamine 3A agonist | 0.159 0.031 DBMET01881 | DBMET01881 | |
| 0.062 | 0.477 | 0.155 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.155 0.125 DBMET01881 | DBMET01881 | |
| 0.022 | 0.438 | 0.135 | UDP-glucose 4-epimerase inhibitor | 0.135 0.035 DBMET02186 0.086 0.079 DBMET02187 | DBMET02186 | |
| 0.068 | 0.487 | 0.257 | Immunomodulator | 0.217 0.145 DBMET02185 0.253 0.112 DBMET02186 0.257 0.109 DBMET02187 | DBMET02187 | |
| 0.039 | 0.462 | 0.195 | Hemostatic | 0.195 0.034 DBMET02186 0.15 0.068 DBMET02187 | DBMET02186 | |
| 0.008 | 0.432 | 0.071 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET02186 | DBMET02186 | |
| 0.049 | 0.479 | 0.24 | Focal adhesion kinase 2 inhibitor | 0.24 0.043 DBMET01881 | DBMET01881 | |
| 0.01 | 0.443 | 0.081 | Platelet activating factor alpha antagonist | 0.081 0.079 DBMET01881 | DBMET01881 | |
| 0.02 | 0.456 | 0.14 | Prolactin inhibitor | 0.14 0.026 DBMET01881 | DBMET01881 | |
| 0.1 | 0.551 | 0.17 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.136 DBMET01881 | DBMET01881 | |
| 0.08 | 0.536 | 0.129 | CC chemokine 6 receptor antagonist | 0.129 0.074 DBMET02186 0.129 0.076 DBMET02187 | DBMET02187 | |
| 0.019 | 0.475 | 0.194 | GABA C receptor agonist | 0.194 0.021 DBMET01881 | DBMET01881 | |
| 0.017 | 0.478 | 0.062 | Factor IXa inhibitor | 0.062 0.025 DBMET02186 | DBMET02186 | |
| 0.012 | 0.473 | 0.057 | Antibiotic Aminoglycoside-like | 0.045 0.017 DBMET02185 0.057 0.01 DBMET02186 0.049 0.014 DBMET02187 | DBMET02186 | |
| 0.006 | 0.48 | 0.057 | Argininosuccinate synthase inhibitor | 0.057 0.039 DBMET01881 | DBMET01881 | |
| 0.036 | 0.513 | 0.26 | DNA synthesis inhibitor | 0.196 0.13 DBMET01881 0.26 0.06 DBMET02186 | DBMET02186 | |
| 0.015 | 0.522 | 0.068 | Histone deacetylase stimulant | 0.068 0.057 DBMET02186 | DBMET02186 | |
| 0.015 | 0.522 | 0.068 | Histone deacetylase SIRT1 stimulant | 0.068 0.057 DBMET02186 | DBMET02186 | |
| 0.005 | 0.519 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET02186 | DBMET02186 | |
| 0.008 | 0.532 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET02186 | DBMET02186 | |
| 0.037 | 0.567 | 0.204 | Angiogenesis inhibitor | 0.204 0.165 DBMET01881 0.19 0.182 DBMET02186 | DBMET01881 | |
| 0.017 | 0.553 | 0.103 | Beta amyloid protein antagonist | 0.1 0.09 DBMET01881 0.103 0.086 DBMET02186 | DBMET02186 | |
| 0.005 | 0.562 | 0.04 | Mannosidase inhibitor | 0.04 0.039 DBMET02186 | DBMET02186 | |
| 0.035 | 0.608 | 0.134 | DNA repair enzyme inhibitor | 0.134 0.049 DBMET02186 | DBMET02186 | |
| 0.049 | 0.631 | 0.15 | Death-associated protein kinase 2 inhibitor | 0.15 0.107 DBMET01881 | DBMET01881 | |
| 0.032 | 0.638 | 0.526 | Antibacterial | 0.238 0.189 DBMET02185 0.526 0.034 DBMET02186 0.509 0.038 DBMET02187 | DBMET02186 | |
| 0.089 | 0.701 | 0.281 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.281 0.239 DBMET01881 | DBMET01881 | |
| 0.018 | 0.636 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.07 DBMET01881 | DBMET01881 | |
| 0.022 | 0.654 | 0.094 | Phosphodiesterase 6D inhibitor | 0.094 0.065 DBMET02186 | DBMET02186 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |